Litcius/Paper detail

mTOR Signaling in Kidney Diseases

Yuan Gui, Chunsun Dai

2020Kidney36058 citationsDOIOpen Access PDF

Abstract

The mammalian target of rapamycin (mTOR), a serine/threonine protein kinase, is crucial in regulating cell growth, metabolism, proliferation, and survival. Under physiologic conditions, mTOR signaling maintains podocyte and tubular cell homeostasis. In AKI, activation of mTOR signaling in tubular cells and interstitial fibroblasts promotes renal regeneration and repair. However, constitutive activation of mTOR signaling in kidneys results in the initiation and progression of glomerular hypertrophy, interstitial fibrosis, polycystic kidney disease, and renal cell carcinoma. Here, we summarize the recent studies about mTOR signaling in renal physiology and injury, and discuss the possibility of its use as a therapeutic target for kidney diseases.

Topics & Concepts

PI3K/AKT/mTOR pathwaymTORC2RPTORCancer researchPodocyteKidneyPolycystic kidney diseaseBiologySignal transductionCell growthCell biologyMedicineEndocrinologymTORC1ProteinuriaBiochemistryRenal Diseases and GlomerulopathiesPI3K/AKT/mTOR signaling in cancerBiomedical Research and Pathophysiology
mTOR Signaling in Kidney Diseases | Litcius